Genome-Wide Association Study of the Postprandial Triglyceride Response Yields Common Genetic Variation in LIPC (Hepatic Lipase)

Supplemental Digital Content is available in the text. Background: The increase in serum triglyceride (TG) concentrations in response to a meal is considered a risk factor for cardiovascular disease. We aimed to elucidate the genetics of the postprandial TG response through genome-wide association studies (GWAS). Methods: Participants of the NEO (Netherlands Epidemiology of Obesity) study (n=5630) consumed a liquid mixed meal after an overnight fast. GWAS of fasting and postprandial serum TG at 150 minutes were performed. To identify genetic variation of postprandial TG independent of fasting TG, we calculated the TG response at 150 minutes by the residuals of a nonlinear regression that predicted TG at 150 minutes as a function of fasting TG. Association analyses were adjusted for age, sex, and principal components in a linear regression model. Next, using the identified variants as determinants, we performed linear regression analyses on the residuals of the postprandial response of 149 nuclear magnetic resonance–based metabolite measures. Results: GWAS of fasting TG and postprandial serum TG at 150 minutes resulted in completely overlapping loci, replicating previous GWAS. From GWAS of the TG response, we identified rs7350789-A (allele frequency=0.36), mapping to hepatic lipase (LIPC), to be associated with a smaller increase in TG concentrations at 150 minutes (β=−0.11; P-value=5.1×10−8). Rs7350789-A was associated with responses of 33 metabolite measures (P-value <1.34×10−3), mainly smaller increases of the TG-component in almost all HDL (high-density lipoprotein) subparticles (HDL-TG), a smaller decrease of HDL diameter and smaller increases of most components of VLDL (very low density lipoprotein) subparticles. Conclusions: GWAS of the TG response identified a variant near LIPC as a main contributor to postprandial TG metabolism independent of fasting TG concentrations, resulting in smaller increases of HDL-TG and VLDL subparticles.

[1]  C. Bouchard,et al.  LDL triglycerides, hepatic lipase activity, and coronary artery disease: An epidemiologic and Mendelian randomization study. , 2019, Atherosclerosis.

[2]  R. Noordam,et al.  Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile , 2018, European Journal of Human Genetics.

[3]  F. Grassmann,et al.  A mega-analysis of expression quantitative trait loci (eQTL) provides insight into the regulatory architecture of gene expression variation in liver , 2018, Scientific Reports.

[4]  M. Pirinen,et al.  Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA , 2016, Nature Communications.

[5]  S. Grundy,et al.  Fatty acid oxidation in normotriglyceridemic men. , 2016, Journal of clinical lipidology.

[6]  E. Nozaki,et al.  Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease , 2015, Heart and Vessels.

[7]  I. Borecki,et al.  Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN). , 2015, Metabolism: clinical and experimental.

[8]  Sebastian M. Armasu,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2015, Nature Genetics.

[9]  D. Gaudet,et al.  Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease. , 2014, Journal of the American College of Cardiology.

[10]  Nick C Fox,et al.  Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease , 2014, PLoS ONE.

[11]  J. Ordovás,et al.  Hypertriglyceridemia Influences the Degree of Postprandial Lipemic Response in Patients with Metabolic Syndrome and Coronary Artery Disease: From the Cordioprev Study , 2014, PloS one.

[12]  J. Borén,et al.  Postprandial hypertriglyceridemia as a coronary risk factor. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[13]  G. Norata,et al.  Postprandial lipemia as a cardiometabolic risk factor , 2014, Current medical research and opinion.

[14]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[15]  Genomics, bears, fruit , 2012, Nature Genetics.

[16]  P. Schnohr,et al.  Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow‐up , 2011, Journal of internal medicine.

[17]  J. Pankow,et al.  LIPC variants in the promoter and intron 1 modify HDL-C levels in a sex-specific fashion. , 2009, Atherosclerosis.

[18]  J. O’Connell,et al.  A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection , 2008, Science.

[19]  Christine M. Williams,et al.  Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism , 2007, British Journal of Nutrition.

[20]  B. Nordestgaard,et al.  Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. , 2007, JAMA.

[21]  P. Ridker,et al.  Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. , 2007, JAMA.

[22]  H. Brewer,et al.  Lipolytic and ligand-binding functions of hepatic lipase protect against atherosclerosis in LDL receptor-deficient mices⃞ Published, JLR Papers in Press, October 27, 2006. , 2007, Journal of Lipid Research.

[23]  Z. Nong,et al.  Hepatic lipase, lipoprotein metabolism, and atherogenesis. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[24]  J. Rutledge,et al.  Postprandial lipemia and cardiovascular disease , 2003, Current atherosclerosis reports.

[25]  S. Deeb,et al.  Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. , 2003, Journal of lipid research.

[26]  S. Deeb,et al.  In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity. , 2000, Journal of lipid research.

[27]  Nicaud,et al.  Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease — the EARS II study , 2000, European journal of clinical investigation.

[28]  J. Björkegren,et al.  Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. , 1999, Circulation.

[29]  J. Ordovás,et al.  Effects of the human apolipoprotein A-I promoter G-A mutation on postprandial lipoprotein metabolism. , 1997, The American journal of clinical nutrition.

[30]  R. Krauss,et al.  A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. , 1996, JAMA.

[31]  L. Chambless,et al.  Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. The Atherosclerosis Risk in Communities (ARIC) Study. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[32]  A. Hofman,et al.  Postprandial Triglyceride Response in Young Adult Men and Familial Risk for Coronary Atherosclerosis , 1994, Annals of Internal Medicine.

[33]  J. Cohn Postprandial lipid metabolism. , 1994, Current opinion in lipidology.

[34]  G. Franceschini,et al.  Increased postprandial lipemia in Apo A-IMilano carriers. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[35]  J. Ordovás,et al.  Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. , 1989, The Journal of biological chemistry.

[36]  M. Taskinen,et al.  Effects of endogenous sex steroids on serum lipoproteins and postheparin plasma lipolytic enzymes. , 1988, The Journal of clinical endocrinology and metabolism.

[37]  T. Iwasaka,et al.  MYOCARDIAL INFARCTION , 1944, British heart journal.

[38]  B. Cortés Rodríguez CordioPrev Study , 2022, ACTUALIDAD MEDICA.